Details

Notice: Guidance on the Clinical Assessment of Abuse Liability for Drugs with Central Nervous System Activity - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Jan 26, 2026 · edition #6
Timestamp: 2026-01-26T03:27:47.961Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/clinical-assessment-abuse-liability-drugs-central-nervous-system.html
Replay URL: https://replay.healtharchive.ca/job-6/20260126032747/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/clinical-assessment-abuse-liability-drugs-central-nervous-system.html#ha_snapshot=414739
ID: 414739
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots